Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
16.78
-0.02 (-0.12%)
Feb 27, 2026, 4:00 PM EST - Market closed
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.06 billion as of February 27, 2026. Its market cap has increased by 47.80% in one year.
Market Cap
1.06B
Enterprise Value
775.04M
1-Year Change
47.80%
Ranking
Category
Stock Price
$16.78
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.06B, an increase of 14.12%. That is a compound annual growth rate of 9.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.06B | 15.32% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 997.56M |
| CytomX Therapeutics | 979.34M |
| GH Research | 976.96M |
| SpyGlass Pharma | 970.54M |
| UroGen Pharma | 967.54M |
| Theravance Biopharma | 965.82M |
| Phathom Pharmaceuticals | 964.59M |
| ArriVent BioPharma | 961.44M |